Creatinine

• Description:

  Creatinine (NSC13123) is a breakdown product of creatine phosphate in muscles.

• Product Name Alternative:

  NSC13123

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H319, H335

• Target:

  Endogenous Metabolite

• Type:

  Natural Products

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease; Cancer

• Assay Protocol:

  https://www.medchemexpress.com/Creatinine.html

• Concentration:

  10mM

• Purity:

  99.92

• Solubility:

  DMSO : 2.5 mg/mL (ultrasonic) |H2O : 33.33 mg/mL (ultrasonic)

• Smiles:

  O=C1N=C (N) N (C) C1

• Molecular Formula:

  C4H7N3O

• Molecular Weight:

  113.12

• Precautions:

  H302, H315, H319, H335

• References & Citations:

  [1]Allen, P.J., Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value. Neurosci Biobehav Rev, 2012. 36 (5) : p. 1442-62.|[2]Levey, A.S., et al., Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med, 2006. 145 (4) : p. 247-54.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Natural Products

• Clinical Information:

  Phase 4

• Isoform:

  Human Endogenous Metabolite; Microbial Metabolite

• CAS Number:

  60-27-5